These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35156636)

  • 1. Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease.
    Bes C; Köybaşı G; İçaçan OC; Yalçın Mutlu M; Yıldırım F
    Eur J Rheumatol; 2022 Jul; 9(3):176-179. PubMed ID: 35156636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.
    Zheng W; Hu X; Zou M; Hu N; Song W; Wang R; Liu Y; Hou Q; Liu Y; Chen X; Cheng Z
    Inflammation; 2023 Feb; 46(1):285-296. PubMed ID: 36044099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Crestani B; Dieudé P
    Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival.
    Yunt ZX; Chung JH; Hobbs S; Fernandez-Perez ER; Olson AL; Huie TJ; Keith RC; Janssen WJ; Goldstein BL; Lynch DA; Brown KK; Swigris JJ; Solomon JJ
    Respir Med; 2017 May; 126():100-104. PubMed ID: 28427540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
    Diesler R; Cottin V
    Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Kakutani T; Hashimoto A; Tominaga A; Kodama K; Nogi S; Tsuno H; Ogihara H; Nunokawa T; Komiya A; Furukawa H; Tohma S; Matsui T
    Mod Rheumatol; 2020 May; 30(3):458-464. PubMed ID: 31116052
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
    Chen N; Diao CY; Gao J; Zhao DB
    Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease.
    Yamakawa H; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Sasaki H; Kuwano K; Matsushima H
    BMC Pulm Med; 2020 Jan; 20(1):25. PubMed ID: 32000736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival.
    Wilson TM; Solomon JJ; Humphries SM; Swigris JJ; Ahmed F; Wang H; Darrah E; Demoruelle MK
    Am J Med Sci; 2023 Jun; 365(6):480-487. PubMed ID: 36918112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes.
    Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
    BMC Pulm Med; 2016 Jul; 16(1):107. PubMed ID: 27461264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD).
    O'Dwyer DN; Armstrong ME; Cooke G; Dodd JD; Veale DJ; Donnelly SC
    Eur J Intern Med; 2013 Oct; 24(7):597-603. PubMed ID: 23916467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Hayashi K; McDermott GC; Vanni KMM; Kowalski E; Qian G; Bade K; Saavedra A; Dieudé P; Dellaripa PF; Doyle TJ; Sparks JA
    Semin Arthritis Rheum; 2024 Feb; 64():152312. PubMed ID: 38056314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.
    Singh N; Varghese J; England BR; Solomon JJ; Michaud K; Mikuls TR; Healy HS; Kimpston EM; Schweizer ML
    Semin Arthritis Rheum; 2019 Dec; 49(3):358-365. PubMed ID: 31153706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
    Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
    Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Latest news on RA-ILD].
    Schreiber T; Hagmeyer L; Kofler DM; Kubacki T; Frank K; Randerath WJ
    Pneumologie; 2022 Sep; 76(9):614-621. PubMed ID: 36104017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
    Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
    Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China.
    Liu L; Fang C; Sun B; Bao R; Zhang H
    Int J Rheum Dis; 2022 Jul; 25(7):795-802. PubMed ID: 35633522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
    Dubey S; Woodhead F
    Rheumatol Int; 2024 Jan; 44(1):99-105. PubMed ID: 38085367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.